BLU2864 is an orally active, highly selective, ATP-competitive PRKACA inhibitor with an IC50 of 0.3 nM, exhibiting anti-tumor activity and potential applications in cancer and polycystic kidney disease research [1] [2].
Molecular Weight:
452.43
Purity:
97.58%
CAS Number:
[2810747-89-6]
Formula:
C24H19F3N4O2
Target:
Others|||PKA
T60170
* VAT and and shipping costs not included. Errors and price changes excepted